about
Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment responseRapid estradiol/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells.Aromatase inhibitor associated musculoskeletal symptoms are associated with reduced physical activity among breast cancer survivorsManaging aromatase inhibitors in breast cancer survivors: not just for oncologistsKinetic analysis of the three-step steroid aromatase reaction of human cytochrome P450 19A1.Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain.Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer.AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studiesThe molecular genetics of breast cancer and targeted therapyThe role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop.Novel aromatase inhibitors selection using induced fit docking and extra precision methods: Potential clinical use in ER-alpha-positive breast cancer.Aromatase inhibitory activity of 1,4-naphthoquinone derivatives and QSAR study.The Growing Role of CDK4/6 Inhibitors in Treating Hormone Receptor-Positive Advanced Breast Cancer.Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.Impact of disease management programs on women with breast cancer in Germany.Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristicsAdjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients.3D-QSAR study of steroidal and azaheterocyclic human aromatase inhibitors using quantitative profile of protein-ligand interactions.Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis.Starfish polysaccharides downregulate metastatic activity through the MAPK signaling pathway in MCF-7 human breast cancer cells.Exploring the Pharmacological Mechanism of Danzhi Xiaoyao Powder on ER-Positive Breast Cancer by a Network Pharmacology Approach.Association of estrogen receptor alpha (ERα) gene polymorphisms with endometrial thickness and lipid profile in women with breast cancer treated with aromatase inhibitors
P2860
Q27694612-6FB14FC4-2FC2-437E-9F67-31C93630ABA6Q33642075-10CB8B9A-A7D5-43A6-A5A7-6907A44D3716Q33714141-09073907-4B06-40C5-8E46-CB5ACDE1CCB3Q33884184-F3D76248-0818-4DF3-80D2-25CCB13B823EQ33885255-C4085494-DA79-4019-9EF4-ECF30C2F6030Q35742012-C5C56135-8727-4B94-8F11-BEC1E8E3080EQ36953997-4FD7FF73-3FDC-44D6-9880-92326C0BFDD7Q37247518-F2672B54-68FC-43CA-A753-9D9E272E4718Q37290512-9406912E-2A2E-418C-96A7-3DF5AFE2A728Q37328397-9447DD26-6791-49E6-AE3C-E2ADDC6AAB3AQ37658821-A5EAD7DA-CCD2-44AC-86ED-30133027D31AQ38615086-CA42E796-B7F0-474B-A246-CB9F59E69914Q38757501-7A0CCE2A-08C0-460D-A9DE-640A4738A10BQ39622594-435571A1-470E-4ACE-BD2A-AF4848A4F236Q39703687-D450117A-F9D6-4D21-B2C6-50939F384722Q41492143-E5163849-F374-4BC7-B6A3-354850705C1FQ42609883-0F4B1335-60A5-4D4C-9AE6-8B140FE82F71Q48119309-FEABA43F-2DC1-47B7-B70C-8D3182AB927AQ48213003-749025D7-AA1E-4C71-AA2F-2CFEB5314E59Q51809566-537339FB-B5AA-4763-928F-CF5FB3A0D25AQ54407079-02CCCA92-8E52-4F97-BC58-88DABFC3D5E8Q54941668-7DA76470-E297-487F-AD58-EBC78A48CC38Q57597460-B1D83BA7-E51B-4C73-BA34-A5D66AD06CD3
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Aromatase inhibitors in breast cancer: an overview.
@ast
Aromatase inhibitors in breast cancer: an overview.
@en
type
label
Aromatase inhibitors in breast cancer: an overview.
@ast
Aromatase inhibitors in breast cancer: an overview.
@en
prefLabel
Aromatase inhibitors in breast cancer: an overview.
@ast
Aromatase inhibitors in breast cancer: an overview.
@en
P1433
P1476
Aromatase inhibitors in breast cancer: an overview.
@en
P2093
Kadri Altundag
Nuhad K Ibrahim
P304
P356
10.1634/THEONCOLOGIST.11-6-553
P577
2006-06-01T00:00:00Z